Search for:

Support Us
News and Press Releases
Events
Careers
ShareEx Login

About ICCR
Our Work
Resources
Resolutions
Membership
Current Initiatives
Donate

Back About ICCR

About ICCR

Who We Are
How We Work

Back Our Work

Our Work

Advancing Worker Justice
Corporate Political Responsibility
- Corporate Lobbying
- Corporate Political Spending
Climate Change and Environmental Justice
Equitable Global Supply Chains
Health Equity
Digital Rights and AI Accountability
Investor Responsibility

Back Resources

Resources

ICCR’s Corporate Examiner

Back Resolutions

Resolutions

Back Membership

Membership

Member Directory
Member Benefits
Become a Member
ICCR's Legacy Award

Back Current Initiatives

Current Initiatives

Back Donate

Donate

Home » In The News » 23% of Bristol Myers-Squibb shareholders back proposal about drug pricing, compensation

23% of Bristol Myers-Squibb shareholders back proposal about drug pricing, compensation

02 May 2018

Pensions & Investments

Always stay up-to-date.

Join Our Mailing List

Subscribe to ICCR's eNewsletter "The Corporate Examiner".

Name

First

Email

CAPTCHA

Interfaith Center on Corporate Responsibility

Mailing Address: 475 Riverside Drive, Suite 1842
New York, NY 10027

Address to receive checks: P.O. Box 22354
New York, NY 10067-2354

info@ICCR.org 212-870-2295

Press Inquiries
Our Annual Report and Financial Statement
Contact Us

donate Become a member

Follow Us

Copyright 2024 EIN: 12-3456789 ICCR Nonprofit Marketing Agency by Elevation Web

Terms of Use Privacy Policy Sitemap